Search results
Results from the WOW.Com Content Network
The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation ...
Image source: Getty Images. 1. Pfizer. Pfizer (NYSE: PFE) makes a great recovery-story buy today. The big pharma company saw annual revenue soar to a record $100 billion in earlier pandemic days ...
The average forward P/E for the healthcare industry is 19.2. A correction might have been overdue, but the company should eventually rebound if its financial results are strong.
2. CVS Health. CVS Health (NYSE: CVS) stock is down by double-digit percentages over the last year, and at the time of this writing is at a price-to-sales ratio of less than 1. The company has had ...
A low price doesn't necessarily mean low quality. That's true with lots of products and services. And it's true with stocks, too. We asked Three Motley Fool contributors to name no-brainer ...
CF drugs have helped Vertex grow revenue into the billions of dollars, with product revenue advancing in the double digits to more than $2.7 billion in the recent quarter.
The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation ...
When I read that the stock price was falling because Amgen's monthly injection only helped people lose an average of 20% of their body weight after 52 weeks -- as opposed to the 25% that analysts ...